RECRUITING

A New Securement Method for External Tunneled Central Venous Access Devices (CVAD)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

An external tunneled central venous access device (CVAD) is a small plastic tube that is tunneled under the skin into a major vein for long-term use (Figure 1). Patients who require a tunneled CVAD are some of the sickest patients we encounter and include oncology, hematology, and gastrointestinal (intestinal failure) patients. These patients are heavily reliant on their tunneled CVAD, which can be a lifeline for long-term administration of chemotherapeutics, IV medications, blood product transfusions, antibiotics, enteral nutrition, blood draws and fluids. Unfortunately, nearly 30% of pediatric external tunneled CVADs fail prior to the completion of treatment. External tunneled CVAD failures lead to unnecessary morbidity and mortality, interruption of medical therapy, and the added costs and risks associated with additional procedural complications. It is hypothesized that a newly designed securement method for external tunneled central venous access devices (CVAD) will reduce catheter-related complications and increase patient, parent and provider satisfaction, compared to the current standard of care, which is a clear transparent film dressing over the catheter exit site. A 20 patient, prospective clinical trial is proposed to address the following specific aims, which will determine if the securement device: 1. Is rated by patients, parents and providers as easy to apply and comfortable for users 2. Reduces CVAD-related complications, such as delayed healing of the tract, catheter-related infections, and episodes of catheter dislodgement 3. Improves the quality of life for patients and their parents 4. Is preferred over the standard, clear transparent dressing alone 5. Requires any design modifications to improve performance and/or comfort of the device

Official Title

A New Securement Method for External Tunneled Central Venous Access Devices (CVAD)

Quick Facts

Study Start:2020-10-19
Study Completion:2024-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04462861

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:31 Days to 18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients aged 31 days to 18 years old, who will undergo surgical placement of a tunneled CVAD
  2. * Any patient with a pre-existing CVAD, who presents to the surgery clinic, emergency department, or is seen as an inpatient consult relating to complications associated with their CVAD
  3. * Patients admitted to the hospital with a pre-existing CVAD for reasons unrelated to the CVAD will be eligible for the study
  1. * Any assenting child or consenting parent/guardian can at any time refuse to participate in the study and will be removed
  2. * Any patient whose parents or legal guardians cannot be reached in person or by telephone to provide consent
  3. * Any prisoners, pregnant women, or person with impaired decision-making capacity

Contacts and Locations

Study Contact

Jenny Stevens, MD
CONTACT
2515899950
jenny.stevens@childrenscolorado.org
Marina Reppucci, MD
CONTACT
2037314914
marina.reppucci@childrenscolorado.org

Principal Investigator

Steven L Moulton, MD
PRINCIPAL_INVESTIGATOR
Children's Hospital Colorado

Study Locations (Sites)

Children's Hospital Colorado
Aurora, Colorado, 54008
United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

  • Steven L Moulton, MD, PRINCIPAL_INVESTIGATOR, Children's Hospital Colorado

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-10-19
Study Completion Date2024-06

Study Record Updates

Study Start Date2020-10-19
Study Completion Date2024-06

Terms related to this study

Keywords Provided by Researchers

  • central venous access device, CVAD

Additional Relevant MeSH Terms

  • Central Venous Catheter Exit Site Infection
  • Central Venous Catheter Related Bloodstream Infection